On May 21, 2014, Jean-Jacques Bienaim tendered his resignation as a member of the Board of Directors of Portola Pharmaceuticals, Inc. effective June 30, 2014, and as a member and the chairperson of the Compensation Committee of the Board, effective immediately. Mr. Bienaim served as a Portola Director since September 2010. On May 27, 2014, the Board appointed John H. Johnson as chairperson of the Compensation Committee.
Portola Pharmaceuticals, Inc.
Equities
US7370101088
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+48.54% | 56.87B | |
+37.15% | 39.72B | |
-6.02% | 39.27B | |
-6.90% | 28.73B | |
+12.97% | 26.21B | |
-16.91% | 19.79B | |
+31.71% | 12.28B | |
+28.18% | 12.23B | |
+0.38% | 12.12B |